Product
NVX-CoV2601
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase 3, Randomized, Double-Blinded Study to Evaluate the Safety and Immunogenicity of Omicron Subvariant and Bivalent SARS-CoV-2 rS Vaccines in Adolescents Previously Vaccinated With mRNA COVID-19 VaccinesStatus: Active (not recruiting), Estimated PCD: 2024-03-22